PANACEA LIFE SCIENCES HOLDINGS, INC.
PLSHDrugs in Pipeline
1
Phase 3 Programs
0
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
0 upcoming, 0 past
No catalysts found.
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Euphorbia tablets | Phase 2 | Hemorrhoids | - | - |
Frequently asked questions
What is in PANACEA LIFE SCIENCES HOLDINGS, INC.'s drug pipeline?→
CatalystAlert tracks 1 drug candidate in PANACEA LIFE SCIENCES HOLDINGS, INC.'s (PLSH) pipeline across Phase 2. Its lead program is Euphorbia tablets (Phase 2). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is PANACEA LIFE SCIENCES HOLDINGS, INC.'s next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for PANACEA LIFE SCIENCES HOLDINGS, INC. (PLSH) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track PLSH biotech catalysts?→
Add PLSH to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow PANACEA LIFE SCIENCES HOLDINGS, INC.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.